NCT06517784View on ClinicalTrials.gov

Insulin Initiation and Adherence Behaviours: a Cross Sectional Survey of Indian HCPs & Patients With Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

752

Participants

Timeline

Start Date

July 5, 2024

Primary Completion Date

August 16, 2024

Study Completion Date

August 16, 2024

Conditions
Type 2 Diabetes
Interventions
OTHER

No treatment given

No treatment given

Trial Locations (1)

Unknown

Novo Nordisk India, Bangalore

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT06517784 - Insulin Initiation and Adherence Behaviours: a Cross Sectional Survey of Indian HCPs & Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter